The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Headline
In this conversation, leaders from Cottage Hospital and Sharon Hospital (part of Northwell Health) share how specialized geriatric behavioral health programs…
Headline
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development. The actions are part of a larger…
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
Hospital and health system leaders gathered June 17 and 18 in Washington, D.C., for U.S. News & World Report’s Healthcare of Tomorrow Conference, focusing…
Headline
In this conversation, Southwest Health’s Kevin Carr, M.D., family medicine physician, and Melissa Carr, M.D., OB/GYN, reflect on the joy of practicing medicine…
Headline
The AHA is now accepting applications through Aug. 18 for the 2027 Quest for Quality Prize, which recognizes hospitals and health systems that provide safe…